NCT02866695 2022-03-09
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
University of California, San Francisco
Phase 4 Completed
Clinical Trials
7 trialsNCT02990221 2019-09-24
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
University of Campania Luigi Vanvitelli
Phase 4 Completed
NCT03508856 2018-04-26
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
Skin Laser & Surgery Specialists
Phase NA Completed
NCT02748902 2017-07-17
Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
TCR Medical Corporation
Phase 1 Completed
NCT02251652 2017-04-26
Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT02242747 2014-09-17
Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis
University of Sao Paulo
Phase NA Completed
NCT01836367 2013-12-31
Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
Icahn School of Medicine at Mount Sinai
Phase 1 Completed